Jake Becraft | BiotechTV

top of page

State of Possible: Strand Therapeutics' Co-Founder & CEO Jake Becraft talks mRNA and getting into the clinic with the company's first program

He describes the intratumoral IL-12 program that is in the clinic today, and the preclinical progress Strand is making on its other...

Company News

Mar 26

The next generation of mRNA beyond vaccines with Strand Therapeutics

Jake Becraft describes emerging new techniques in using mRNA and gives BiotechTV a tour of Strand’s Fenway HQ to show us the R&D process.

Tech + Tours

Sep 5, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

State of Possible: Strand Therapeutics' Co-Founder & CEO Jake Becraft talks mRNA and getting into the clinic with the company's first program

The next generation of mRNA beyond vaccines with Strand Therapeutics

Follow BiotechTV

Sponsors

Sponsor Spotlight